Movement Alert｜Ali Health Rises 3.49% in Regular Trading, Innovative Drug First-Launch Platform Effect Continues to Build Momentum

Market Focus

Jul 03

On July 3, Ali Health rose 3.49% in regular trading, trading at HK$3.29/share, with turnover of HK$92.56 million, extending the previous session's gains.

On the news front, Hengrui Medicine's Class 1 innovative drug Ruiming and Yangtze River Pharmaceutical's Class 1 new drug Taituotuo were simultaneously launched exclusively on Ali Health's platform on June 29, reinforcing the company's positioning as a first-launch destination for new specialty drugs. The concentrated selection of Ali Health as the exclusive online first-launch channel by two blockbuster innovative drugs validates the company's channel value and digital service capabilities in the commercialization of innovative pharmaceuticals. Management has previously outlined FY2027 revenue growth guidance of 10% to 15% year-over-year, with the innovative drug category identified as the core growth driver.

Within the Internet and Direct Marketing Retail sector, JD Health rose 5.15%, PA Good Doctor rose 5.09%, JD-SW rose 1.75%, BABA-W rose 0.53%, and Meituan-W rose 0.21%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1199887108"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199887108\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199887108?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 09:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199887108","market":"us","top_or_hot":-1,"title":"Movement Alert｜Ali Health Rises 3.49% in Regular Trading, Innovative Drug First-Launch Platform Effect Continues to Build Momentum","media":"Market Focus","content":"<p><p>On July 3, Ali Health rose 3.49% in regular trading, trading at HK$3.29/share, with turnover of HK$92.56 million, extending the previous session's gains.</p><p>On the news front, Hengrui Medicine's Class 1 innovative drug Ruiming and Yangtze River Pharmaceutical's Class 1 new drug Taituotuo were simultaneously launched exclusively on Ali Health's platform on June 29, reinforcing the company's positioning as a first-launch destination for new specialty drugs. The concentrated selection of Ali Health as the exclusive online first-launch channel by two blockbuster innovative drugs validates the company's channel value and digital service capabilities in the commercialization of innovative pharmaceuticals. Management has previously outlined FY2027 revenue growth guidance of 10% to 15% year-over-year, with the innovative drug category identified as the core growth driver.</p><p>Within the Internet and Direct Marketing Retail sector, JD Health rose 5.15%, PA Good Doctor rose 5.09%, JD-SW rose 1.75%, BABA-W rose 0.53%, and Meituan-W rose 0.21%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Ali Health Rises 3.49% in Regular Trading, Innovative Drug First-Launch Platform Effect Continues to Build Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Ali Health Rises 3.49% in Regular Trading, Innovative Drug First-Launch Platform Effect Continues to Build Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-03 09:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 3, Ali Health rose 3.49% in regular trading, trading at HK$3.29/share, with turnover of HK$92.56 million, extending the previous session's gains.</p><p>On the news front, Hengrui Medicine's Class 1 innovative drug Ruiming and Yangtze River Pharmaceutical's Class 1 new drug Taituotuo were simultaneously launched exclusively on Ali Health's platform on June 29, reinforcing the company's positioning as a first-launch destination for new specialty drugs. The concentrated selection of Ali Health as the exclusive online first-launch channel by two blockbuster innovative drugs validates the company's channel value and digital service capabilities in the commercialization of innovative pharmaceuticals. Management has previously outlined FY2027 revenue growth guidance of 10% to 15% year-over-year, with the innovative drug category identified as the core growth driver.</p><p>Within the Internet and Direct Marketing Retail sector, JD Health rose 5.15%, PA Good Doctor rose 5.09%, JD-SW rose 1.75%, BABA-W rose 0.53%, and Meituan-W rose 0.21%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1199887108","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199887108","pubTimestamp":1783043281,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 3, Ali Health rose 3.49% in regular trading, trading at HK$3.29/share, with turnover of HK$92.56 million, extending the previous session's gains.On the news front, Hengrui Medicine's Class 1...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"运动快讯|阿里健康常规交易涨3.49%创新药首发平台效应持续蓄势","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"On July 3, Ali Health rose 3.49% in regular trading, trading at HK$3.29/share, with turnover of HK$92.56 million, extending the previous session's gains.On the news front, Hengrui Medicine's Class 1 innovative drug Ruiming and Yangtze River Pharmaceutical's Class 1 new drug Taituotuo were simultaneously launched exclusively on Ali Health's platform on June 29, reinforcing the company's positioning as a first-launch destination for new specialty drugs. The concentrated selection of Ali Health as the exclusive online first-launch channel by two blockbuster innovative drugs validates the company's channel value and digital service capabilities in the commercialization of innovative pharmaceuticals. Management has previously outlined FY2027 revenue growth guidance of 10% to 15% year-over-year, with the innovative drug category identified as the core growth driver.Within the Internet and Direct Marketing Retail sector, JD Health rose 5.15%, PA Good Doctor rose 5.09%, JD-SW rose 1.75%, BABA-W rose 0.53%, and Meituan-W rose 0.21%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}